Free Trial

Clearside Biomedical (CLSD) News Today

Clearside Biomedical logo
$1.05 +0.02 (+1.94%)
(As of 11/20/2024 ET)
StockNews.com Upgrades Clearside Biomedical (NASDAQ:CLSD) to "Hold"
Clearside Biomedical, Inc. stock logo
What is HC Wainwright's Forecast for CLSD FY2024 Earnings?
Clearside Biomedical, Inc. (NASDAQ:CLSD - Free Report) - Research analysts at HC Wainwright increased their FY2024 earnings estimates for Clearside Biomedical in a research report issued to clients and investors on Wednesday, November 13th. HC Wainwright analyst Y. Chen now anticipates that the c
Clearside Biomedical, Inc. stock logo
Clearside Biomedical, Inc. (NASDAQ:CLSD) Sees Significant Decline in Short Interest
Clearside Biomedical, Inc. (NASDAQ:CLSD - Get Free Report) saw a significant decrease in short interest in the month of October. As of October 31st, there was short interest totalling 1,760,000 shares, a decrease of 9.7% from the October 15th total of 1,950,000 shares. Based on an average daily trading volume, of 735,800 shares, the short-interest ratio is presently 2.4 days.
Clearside Biomedical, Inc. stock logo
Clearside Biomedical (NASDAQ:CLSD) Raised to Hold at StockNews.com
StockNews.com raised Clearside Biomedical from a "sell" rating to a "hold" rating in a research note on Saturday.
Clearside Biomedical, Inc. stock logo
Clearside Biomedical's (CLSD) Buy Rating Reaffirmed at Chardan Capital
Chardan Capital reaffirmed a "buy" rating and set a $6.00 price target on shares of Clearside Biomedical in a research report on Friday.
Clearside Biomedical, Inc. stock logo
Clearside Biomedical (NASDAQ:CLSD) Receives "Buy" Rating from HC Wainwright
HC Wainwright restated a "buy" rating and set a $6.00 target price on shares of Clearside Biomedical in a research report on Thursday.
Oppenheimer Keeps Their Buy Rating on Clearside Biomedical (CLSD)
Clearside Biomedical, Inc. stock logo
Needham & Company LLC Reaffirms "Buy" Rating for Clearside Biomedical (NASDAQ:CLSD)
Needham & Company LLC restated a "buy" rating and issued a $6.00 price objective on shares of Clearside Biomedical in a research report on Wednesday.
Clearside Biomedical Reports Positive Q3 2024 Results
Clearside Biomedical, Inc. stock logo
Clearside Biomedical (NASDAQ:CLSD) Rating Lowered to "Sell" at StockNews.com
StockNews.com cut shares of Clearside Biomedical from a "hold" rating to a "sell" rating in a research report on Friday.
Clearside Biomedical, Inc. stock logo
Clearside Biomedical, Inc. (NASDAQ:CLSD) Shares Sold by Rosalind Advisors Inc.
Rosalind Advisors Inc. lessened its holdings in Clearside Biomedical, Inc. (NASDAQ:CLSD - Free Report) by 95.1% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 127,220 shares of the company's stock after selling 2,465,3
Clearside Biomedical, Inc. stock logo
Clearside Biomedical (CLSD) to Release Earnings on Tuesday
Clearside Biomedical (NASDAQ:CLSD) will be releasing earnings after the market closes on Tuesday, November 12, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=263163)
Clearside Biomedical appoints Gibney as new Chair of board of directors
Clearside Biomedical, Inc. stock logo
Clearside Biomedical, Inc. (NASDAQ:CLSD) Insider Purchases $36,500.00 in Stock
Clearside Biomedical, Inc. (NASDAQ:CLSD - Get Free Report) insider Ngai Hang Victor Chong acquired 36,500 shares of the business's stock in a transaction dated Friday, November 1st. The stock was purchased at an average cost of $1.00 per share, for a total transaction of $36,500.00. Following the completion of the acquisition, the insider now directly owns 100,000 shares of the company's stock, valued at approximately $100,000. This trade represents a 0.00 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at this link.
Clearside Biomedical, Inc. stock logo
Clearside Biomedical, Inc. (NASDAQ:CLSD) Given Consensus Recommendation of "Buy" by Analysts
Clearside Biomedical, Inc. (NASDAQ:CLSD - Get Free Report) has been given a consensus rating of "Buy" by the six analysts that are presently covering the company, Marketbeat reports. Six analysts have rated the stock with a buy rating. The average 1-year price target among brokers that have covere
Clearside Biomedical, Inc. stock logo
Clearside Biomedical, Inc. (NASDAQ:CLSD) Sees Significant Growth in Short Interest
Clearside Biomedical, Inc. (NASDAQ:CLSD - Get Free Report) saw a significant increase in short interest in the month of October. As of October 15th, there was short interest totalling 1,950,000 shares, an increase of 646.6% from the September 30th total of 261,200 shares. Based on an average daily volume of 718,700 shares, the days-to-cover ratio is presently 2.7 days.
Clearside Biomedical, Inc. stock logo
Clearside Biomedical (NASDAQ:CLSD) Rating Increased to Hold at StockNews.com
StockNews.com raised shares of Clearside Biomedical from a "sell" rating to a "hold" rating in a report on Friday.
Clearside Biomedical, Inc. stock logo
Chardan Capital Reaffirms "Buy" Rating for Clearside Biomedical (NASDAQ:CLSD)
Chardan Capital reaffirmed a "buy" rating and set a $6.00 target price on shares of Clearside Biomedical in a report on Monday.
Clearside Biomedical, Inc. stock logo
Clearside Biomedical, Inc. (NASDAQ:CLSD) Given Average Rating of "Buy" by Analysts
Clearside Biomedical, Inc. (NASDAQ:CLSD - Get Free Report) has been given a consensus recommendation of "Buy" by the six brokerages that are presently covering the firm, MarketBeat reports. Six analysts have rated the stock with a buy rating. The average 1 year target price among brokers that have
Clearside Biomedical, Inc. stock logo
Armistice Capital LLC Decreases Position in Clearside Biomedical, Inc. (NASDAQ:CLSD)
Armistice Capital LLC lessened its stake in Clearside Biomedical, Inc. (NASDAQ:CLSD - Free Report) by 46.0% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 2,136,000 shares of the company's stock after selling 1,820,000 shar
Clearside Biomedical, Inc. stock logo
Clearside Biomedical, Inc. (NASDAQ:CLSD) Sees Large Increase in Short Interest
Clearside Biomedical, Inc. (NASDAQ:CLSD - Get Free Report) saw a large increase in short interest during the month of August. As of August 31st, there was short interest totalling 335,200 shares, an increase of 86.0% from the August 15th total of 180,200 shares. Based on an average daily trading volume, of 220,800 shares, the days-to-cover ratio is currently 1.5 days.
Clearside Biomedical, Inc. stock logo
Clearside Biomedical, Inc. (NASDAQ:CLSD) Receives Average Rating of "Buy" from Brokerages
Clearside Biomedical, Inc. (NASDAQ:CLSD - Get Free Report) has been assigned a consensus rating of "Buy" from the six brokerages that are covering the company, Marketbeat.com reports. Six research analysts have rated the stock with a buy rating. The average twelve-month target price among brokerag
Clearside Biomedical, Inc. stock logo
Clearside Biomedical (NASDAQ:CLSD) Shares Pass Below 50 Day Moving Average of $1.12
Clearside Biomedical (NASDAQ:CLSD) Shares Pass Below 50 Day Moving Average of $1.12
Clearside Biomedical, Inc. stock logo
Clearside Biomedical's (CLSD) Buy Rating Reiterated at HC Wainwright
HC Wainwright reaffirmed a "buy" rating and issued a $5.00 price objective on shares of Clearside Biomedical in a research note on Tuesday.
Get Clearside Biomedical News Delivered to You Automatically

Sign up to receive the latest news and ratings for CLSD and its competitors with MarketBeat's FREE daily newsletter.

2025 AI Stock Picks: 2 Hidden Gems Under $10/Share (Ad)

The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.

👉[Click here to get your FREE report delivered instantly!]

CLSD Media Mentions By Week

CLSD Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CLSD
News Sentiment

0.65

0.45

Average
Medical
News Sentiment

CLSD News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CLSD Articles
This Week

13

2

CLSD Articles
Average Week

Get Clearside Biomedical News Delivered to You Automatically

Sign up to receive the latest news and ratings for CLSD and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:CLSD) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners